A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Insider ownership 30% and increasing. Charts look like a whipsaw at the moment but also like a bottom forming, which is consistent with my understanding of insider buying patterns.
Hardly conclusive, of course, but it's now been more than 2 years since any analysts downgraded this. In the meantime there have been 2 coverage initiations at "Outperform".
Who initiated the coverages ?